Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saye Khoo

Showing results (51-60 of 282) with videos related to

Pageof 29
Sort By:
Clinical Pharmacokinetics|September 24, 2014
Use of in vitro to in vivo extrapolation to predict the optimal strategy for patients switching from efavirenz to maraviroc or nevirapineAlessandro Schipani, David Back, Andrew Owen, et al.
AIDS (London, England)|September 16, 2015
Increasing use of 'party drugs' in people living with HIV on antiretrovirals: a concern for patient safetyMargherita Bracchi, David Stuart, Richard Castles, et al.
The Journal of Antimicrobial Chemotherapy|December 30, 2015
Simulation of the impact of rifampicin on once-daily darunavir/ritonavir pharmacokinetics and dose adjustment strategies: a population pharmacokinetic approachLaura Dickinson, Alan Winston, Marta Boffito, et al.
International Journal of STD & AIDS|August 4, 2018
Polymorphisms of tenofovir disoproxil fumarate transporters and risk of kidney tubular dysfunction in HIV-positive patients: genetics of tenofovir transportersMohammed I Danjuma, Deirdre Egan, Ibrahim Yusuf Abubeker, et al.
Postgraduate Medical Journal|May 23, 2020
Use of specific antimicrobials for COVID-19: should we prescribe them now or wait for more evidence?Abdullah AlAkhras, Ahmed Husein AlMessabi, Hala Abuzeid, et al.
Bioanalysis|June 9, 2023
Application of novel plasma separation filter cards for quantification of nucleoside/nucleotide reverse transcriptase inhibitor di/triphosphates in dried blood spots using LC-MSBeth Thompson, Sujan Dilly-Penchala, Alieu Amara, et al.
The Lancet. HIV|December 4, 2024
Denying access to long-acting injectable treatment for HIV: an open letterThokozile Malaba, Jessica Henn, Catriona Waitt, et al.
Antiviral Therapy|June 3, 2010
Steady-state nevirapine, lamivudine and stavudine levels in Malawian HIV-infected children on antiretroviral therapy using split Triomune 30 tabletsGoenke Poerksen, Louisa Pollock, Peter Moons, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 30, 2010
Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compoundsLaura Else, Victoria Watson, John Tjia, et al.
Pharmacogenetics and Genomics|June 21, 2014
CYP3A4*22 (c.522-191 C>T; rs35599367) is associated with lopinavir pharmacokinetics in HIV-positive adultsAdeniyi Olagunju, Alessandro Schipani, Marco Siccardi, et al.
Pageof 29

Showing results (51-60 of 282) with videos related to

Sort By:
Pageof 29
Clinical Pharmacokinetics|September 24, 2014
Use of in vitro to in vivo extrapolation to predict the optimal strategy for patients switching from efavirenz to maraviroc or nevirapineAlessandro Schipani, David Back, Andrew Owen, et al.
AIDS (London, England)|September 16, 2015
Increasing use of 'party drugs' in people living with HIV on antiretrovirals: a concern for patient safetyMargherita Bracchi, David Stuart, Richard Castles, et al.
The Journal of Antimicrobial Chemotherapy|December 30, 2015
Simulation of the impact of rifampicin on once-daily darunavir/ritonavir pharmacokinetics and dose adjustment strategies: a population pharmacokinetic approachLaura Dickinson, Alan Winston, Marta Boffito, et al.
International Journal of STD & AIDS|August 4, 2018
Polymorphisms of tenofovir disoproxil fumarate transporters and risk of kidney tubular dysfunction in HIV-positive patients: genetics of tenofovir transportersMohammed I Danjuma, Deirdre Egan, Ibrahim Yusuf Abubeker, et al.
Postgraduate Medical Journal|May 23, 2020
Use of specific antimicrobials for COVID-19: should we prescribe them now or wait for more evidence?Abdullah AlAkhras, Ahmed Husein AlMessabi, Hala Abuzeid, et al.
Bioanalysis|June 9, 2023
Application of novel plasma separation filter cards for quantification of nucleoside/nucleotide reverse transcriptase inhibitor di/triphosphates in dried blood spots using LC-MSBeth Thompson, Sujan Dilly-Penchala, Alieu Amara, et al.
The Lancet. HIV|December 4, 2024
Denying access to long-acting injectable treatment for HIV: an open letterThokozile Malaba, Jessica Henn, Catriona Waitt, et al.
Antiviral Therapy|June 3, 2010
Steady-state nevirapine, lamivudine and stavudine levels in Malawian HIV-infected children on antiretroviral therapy using split Triomune 30 tabletsGoenke Poerksen, Louisa Pollock, Peter Moons, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 30, 2010
Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compoundsLaura Else, Victoria Watson, John Tjia, et al.
Pharmacogenetics and Genomics|June 21, 2014
CYP3A4*22 (c.522-191 C>T; rs35599367) is associated with lopinavir pharmacokinetics in HIV-positive adultsAdeniyi Olagunju, Alessandro Schipani, Marco Siccardi, et al.
Pageof 29